Reckitt says US court grants new trial in preterm formula case
Portfolio Pulse from
Reckitt announced that a US circuit court has allowed plaintiffs to seek a new trial in a case accusing Reckitt and Abbott of not warning about the risks of premature-infant formulas.
March 14, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Abbott is involved in a legal case where a US court has allowed a new trial regarding allegations of not warning about risks of premature-infant formulas.
The legal case could lead to financial liabilities or reputational damage for Abbott, potentially affecting its stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80